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Although bacteraemia caused by obligate anaerobic bacteria is a rare event, this phenomenon
will be an emerging problem among oncohaematological patients. We report four cases of
bacteraemia caused by Fusobacterium nucleatum in febrile, neutropenic patients over a 10
month period. All patients had haematological malignancy and severe neutropenia, and three of
them suffered from oral mucositis or oedema of the oral mucosal surfaces, which was the
probable portal of entry. All isolated strains were susceptible to standard anti-anaerobic
antibiotics.
Introduction
Bacteraemia caused by anaerobic bacteria is a rare event; its
incidence is about 0.5–9% of all positive blood cultures
(James & Al-Shafi, 2000; Ortiz & Sande, 2000; Goldstein,
1996). In spite of this low incidence, in most of the cases it
is associated with high mortality, because of the delay in
starting adequate treatment, and the inconsistent use of
anaerobic culture methods. Naturally its outcome is also
correlated with the patient’s age and underlying disease.
Since anaerobes are a predominant part of the normal
commensal flora of mucous membranes, the majority of
infections caused by these bacteria are of endogenous
origin. When the oral cavity, the intestine or the female
genital organs are the source of these infections, mixed
anaerobic bacteria may be the predominant isolates from
blood cultures (Brook, 2002). Bacteraemia caused by
fusobacteria is characteristic in neutropenic patients;
however, this organism is not a frequent causative agent
of septicaemia (Candoni et al., 2003; Fanourgiakis
et al., 2003).
During a 10 month period, four cases of bacteraemia caused
by Fusobacterium nucleatum were detected in patients with
haematological malignancies in the Haematology Unit,
University Hospital of Szeged, Hungary. Our aims were to
analyse retrospectively the clinical background and the
microbiological characteristics of these cases, to draw
attention to the importance of the regular use of anaerobic
blood culture bottles, the necessity of the early recognition of
anaerobic bacteraemia and the use of anti-anaerobic
antibiotics as part of the empiric therapy.
Case report
Case 1
A 51-year-old woman was admitted to the Haematology
Unit with acute myelomonocytic leukaemia; therefore,
cytosine arabinoside (2200 mg per day), mitoxantrone
(15 mg per day) and etoposide (220 mg per day) therapies
were given over 5 days. At the end of the chemotherapy,
the patient had developed fever and oropharyngeal
mucositis of World Health Organization (WHO) grade 3
(ulcers, liquid diet is required) (Miller et al., 1981).
Routine laboratory investigations revealed that the white
blood cell and neutrophil counts were 5500 cells mm23
and 100 neutrophils mm23, respectively. During the febrile
episode, blood samples for cultures were drawn through a
central venous catheter (two pairs of aerobic and anaerobic
bottles) and the peripheral vein (two pairs of aerobic and
anaerobic bottles); after that, empiric antibiotic treatment,
levofloxacin (500 mg once a day), was started. On the basis
of routine laboratory procedures, blood cultures were sent
immediately to the laboratory, where they were incubated
in a BACTEC blood culture system (BD BACTEC 9120; BD
Diagnostic Systems) until a positive signal was generated. If
a positive signal appeared, in the case of the aerobic bottle,
blood was inoculated onto the surface of aerobic agar
plates (sheep blood agar, chocolate agar, eosin methylene
blue and Sabouraud agar plates); while in the case of the
anaerobic bottle, besides aerobic agar plates, Columbia agar
base (Oxoid) supplemented with 5% (v/v) cattle blood,
haemin and vitamin K1 was also inoculated. For aerobic
bacteria, the plates were incubated at 37 uC in a 5% CO2-
containing environment for 24 h or in ambient air. For the
isolation of anaerobic bacteria, the anaerobic plate was
incubated in an atmosphere of 90% N2, 5% H2 and 5%Abbreviation: WHO, World Health Organization.
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CO2 (Bactron chamber; Sheldon Manufacturing). After
getting a positive signal, phase-contrast microscopy and
Gram staining were performed, and on the basis of the
microscopy findings, direct susceptibility testing was set
up for aerobic bacteria. In the cases of the two aerobic
blood culture bottles collected by venepuncture and
through the central venous catheter, positive signals were
generated, and after 24 h of incubation Staphylococcus
haemolyticus grew in these bottles. On the basis of
antibiotic susceptibility results, the patient was treated
with teicoplanin (daily dose 400 mg) for 14 days. At the
same time, after 50 and 77 h of incubation for the
anaerobic blood culture bottles collected by venepuncture
and through the central venous catheter, positive signals
were obtained. Phase-contrast microscopy examination
showed non-motile, slender rods with pointed ends,
which proved to be Gram-negative by staining. On the
basis of these findings, the possibility of Fusobacterium sp.
arose; therefore, metronidazole therapy (500 mg three
times a day) was started. Colonies on the anaerobic blood
agar plate supplemented with 1 mg vitamin K1 l
21 and
0.3 g cysteine l21 were irregular with a flecked appear-
ance. The organism did not show growth in the presence
of 20% bile. Carbohydrate fermentations and lipase
production were negative, while the isolated strain pro-
duced indole. The strain was identified as F. nucleatum
using commercial biochemical tests. Antibiotic suscept-
ibility testing was performed using the Etest method (AB
Biodisk), and the strain was susceptible to penicillin,
amoxicillin/clavulanic acid, cefoxitine, imipenem, metro-
nidazole and clindamycin. Two weeks later, after remis-
sion, the patient was discharged home.
Case 2
A 71-year-old woman, who suffered from acute myeloid
leukaemia, was admitted to the University Hospital of
Szeged with a febrile episode, mucositis WHO grade 1
(soreness and erythema) and the possibility of perianal
abscess. Laboratory investigations showed neutropenia and
a high C-reactive protein level. Chest radiography revealed
pulmonary infiltration in the upper right side of the lung.
Blood culture samples (aerobic and anaerobic bottles) were
taken from the peripheral vein, and empiric antibiotic
therapy, piperacillin/tazobactam (4.5 g three times a day),
was started. Blood culture bottles were processed according
to the above-mentioned routine laboratory procedures.
There was no evidence of perianal abscess by surgical
examination and after 47 h of incubation, phase-contrast
microscopy examination from the positive anaerobic blood
culture bottle showed very slender, long, non-motile rods.
Species level identification and antibiotic-susceptibility
testing were performed as described above. In spite of the
in vitro susceptibility of the isolated strain to piperacillin/
tazobactam, because of persistent fever, 5 days later the
antibiotic therapy was changed to meropenem (1 g three
times per day). After this, the patient became afebrile and
she was discharged home.
Case 3
A 46-year-old man was diagnosed with acute pre-B-cell
lymphoblastic leukaemia. In his second remission, after
consolidation therapy (high dose cytosine arabinoside and
mitoxantrone), he had developed fever and neutropenia
without mucositis despite the chemotherapeutic treatment.
Blood samples (aerobic and anaerobic bottles) for culture
were taken according to routine procedures, and the
anaerobic blood culture bottle gave a positive signal after
35 h of incubation. On the basis of findings of the
microscopic examination, the possibility of bacteraemia
caused by Fusobacterium sp. arose and empiric antibiotic
therapy, piperacillin/tazobactam (4.5 g three times per
day), was started. Species level identification and antibiotic
susceptibility testing were performed. On the 11th day of
adequate antibiotic therapy, the patient was discharged
home.
Case 4
A 61-year-old woman with acute myeloid leukaemia was
admitted to the Haematology Unit because of fever, cough
and dyspnoea. Her C-reactive protein level was elevated,
and her absolute neutrophil count was 200 neutrophils
mm23. She had severe oropharyngeal mucositis of WHO
grade 3, while chest radiography showed pulmonary
infiltration on the left side of the lung. Blood culture
samples (aerobic and anaerobic bottles) were taken and
after that empiric antibiotic therapy, ciprofloxacin (200 mg
twice a day) was started because of persistent fever. After
87 h of incubation in the case of anaerobic bottle, we got a
positive signal. On the basis of the findings of the micro-
scopic examination, amoxicillin/clavulanic acid (1.2 g
every 12 h for 10 days) was started, and F. nucleatum grew
from the positive blood culture bottle. On the 30th day of
hospitalization, the patient was discharged home.
Microbiological investigations
During the febrile period, at least one pair of blood samples
was taken in aerobic and anaerobic bottles from all
patients. Blood culture bottles were placed immediately
in the BACTEC system (BACTEC 9120; BD Diagnos-
tic Systems), and incubated at 37 uC until a positive
fluorescence signal was detected. When positive signals
were generated after 35–87 h of incubation, phase-contrast
microscopy examination and Gram-staining preparation
were performed and subcultures were plated on anaerobic
blood agar plates supplemented with 1 mg vitamin K1 l
21
and 0.3 g cysteine l21 for the isolation of anaerobic
bacteria. For the isolation of aerobic bacteria, sheep blood
agar, chocolate agar, eosin methylene blue and Sabouraud
agar were inoculated. Anaerobic plates were placed in an
anaerobic chamber (Bactron; Sheldon Manufacturing) for
48 h at 37 uC, while the aerobic plates were incubated at
37 uC, for 24 h in 5% CO2, and in ambient air. Identi-
fication of the isolated strains was carried out according to
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the Wadsworth Manual (Jouseimies-Somer et al., 2002)
[e.g. special-potency discs, use of BBE (bacteroides bile
aesculin agar) (for the detection of growth in the presence
of bile) and EYA(egg yolk agar) (for the detection of lipase
activity) media] and using API Rapid ID 32A
(bioMe´rieux). We also checked the cellular and colony
morphologies, fluorescence under UV light and greening
of blood agar after exposure to air. Determination of the
MICs for penicillin, amoxicillin/clavulanic acid, cefoxi-
tine, imipenem, metronidazole and clindamycin was
carried out using the Etest method (AB Biodisk) and the
results were interpreted according to the recommenda-
tions of the Clinical and Laboratory Standards Institute
(CLSI, 2007).
Discussion
Microbiological investigation revealed the presence of F.
nucleatum in the blood cultures of the four patients. In
three cases, only one anaerobic bottle gave a positive signal,
while in one case, two aerobic blood culture bottles
collected at the same time were positive for coagulase-
negative staphylococci. All patients had clinical symptoms
of sepsis; since the isolated F. nucleatum is not a member of
the skin flora, its role as a possible contaminant was
excluded. The mean number of days required for the blood
culture bottles to become positive was 2.6 days (range 35
to 87 h). All four F. nucleatum strains proved to be
susceptible to all tested anti-anaerobic antibiotics (penicil-
lin, amoxicillin/clavulanic acid, clindamycin, cefoxitin,
imipenem and metronidazole). In all cases, the underlying
disease was haematological malignancy, acute myeloid or
lymphoblastic leukaemia. Two patients (cases 1 and 3)
received chemotherapy before the development of a febrile
period, one of them had confirmed oropharyngeal
mucositis, while in the second case, there were no clinical
symptoms of this, but the therapy used is known to make
patients susceptible to the development of oral mucositis.
In case 4, the patient had severe oropharyngeal mucositis
without previous chemotherapy, while in case 2, the
peritonsillar region and the soft palate were oedematous.
Fanourgiakis et al. (2003) showed 15 cases of bacteraemia
caused by Fusobacterium spp. over a 6.5 year period.
Among these, 13 patients were neutropenic, their mean age
was 53 years, and the majority of them had underlying
haematological malignancies and oral postchemotherapy
mucositis. As oral mucositis could be observed in almost all
patients, this was the probable source of the bacteraemia.
This study also demonstrated that a relatively long incuba-
tion period (about 5 days) was sometimes necessary for
getting positive signals in the case of anaerobic bottles.
On the basis of literature data, between the 1960s and
1970s, the incidence of anaerobic bacteraemia increased
due to improvements in anaerobic laboratory culture
methods, later this was followed by a decrease, while
between 1993 and 2004, the mean incidence of anaerobic
bacteraemias increased again (Ortiz & Sande, 2000;
Dorsher et al., 1991; Lassmann et al., 2007). The majority
of patients with anaerobic bacteraemia had predisposing
factors, such as severe neutropenia, chemotherapy-induced
oral mucositis or other types of oral lesions (Landsaat et al.,
1995; Vidal et al., 2000). Because of these, prophylaxis with
anaerobic coverage for postchemotherapy neutropenia
should be reasonable according to some publications; how-
ever, the use of prophylaxis may contribute to the selection
of resistant strains from the indigenous flora, and therefore
an optimal decision is very difficult (Fanourgiakis et al.,
2003; Landsaat et al., 1995).
In 2008, Goldstein and colleagues showed that laboratories
that routinely performed anaerobic cultures, processed
mainly blood and wound cultures for anaerobes, at the same
time, species level identification and antimicrobial suscept-
ibility testing needed improvement (Goldstein et al., 2008).
As a consequence of limited susceptibility data for this
topic, clinicians frequently apply broad-spectrum anti-
biotics; this may lead to the development of new resistance
mechanisms in anaerobic bacteria, the outcome of infec-
tions caused by anaerobes may worsen, mainly if the patient
is not treated with the appropriate antibiotics, and the
emergence and spread of resistant strains may increase the
financial burden on health care (Goldstein et al., 2008;
Hecht, 2007). The importance of adequate therapy for
anaerobic bacteraemia was also shown by Salonen et al.
(1998). They examined the incidence of anaerobic bacter-
aemia and mortality. If the patient received adequate
antimicrobial therapy before the results of blood cultures,
the mortality was 18%. If ineffective antimicrobial therapy
was changed to effective on the basis of culture results, the
mortality proved to be 17%, while if the patient was treated
with ineffective antibiotics the mortality reached 55%
(Salonen et al., 1998). In many cases, to reduce the costs of
microbiological investigations, there is no routine perform-
ance of anaerobic blood culture. Clinicians request
anaerobic blood culture only in special cases, such as
during surgical interventions or in the case of certain
patients groups (e.g. haematological patients). On the basis
of the work by Rosenblatt (1997), the presentation of
anaerobic infections is frequently atypical and originates
from unsuspected sources; thus, development of these is
unpredictable. This observation also confirmed the routine
use of anaerobic blood cultures (Rosenblatt, 1997). The
importance of the routine anaerobic blood cultures is also
emphasized by the fact that the use of anaerobic bottles may
increase the yield of both obligate and facultative anaerobes,
including streptococci (Rosenblatt, 1997).
Because of the aggressive treatment of haematological
patients, mucositis commonly occurs with consequent
translocation of commensal flora members; thus, in this
patient group, we need to think about anaerobes as causative
agents of bacteraemia and anti-anaerobic coverage in
empiric therapy is desirable. As a consequence of the
emergence of highly virulent strains and the increasing
frequency of resistant isolates, the routine use of anaerobic
blood culture is a reasonable choice.
G. Terhes and others
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